THERANEXUS has a total of 11 patent applications. Its first patent ever was published in 2016. It filed its patents most often in EPO (European Patent Office), Australia and Brazil. Its main competitors in its focus markets pharmaceuticals are SOLVON ARZNEI VERTRIEB LIZENZ, CHARLESTON LAB INC and LOCL PHARMA INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 2 | |
#2 | Australia | 1 | |
#3 | Brazil | 1 | |
#4 | Canada | 1 | |
#5 | China | 1 | |
#6 | Israel | 1 | |
#7 | Republic of Korea | 1 | |
#8 | Mexico | 1 | |
#9 | United States | 1 | |
#10 | WIPO (World Intellectual Property Organization) | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds |
# | Name | Total Patents |
---|---|---|
#1 | Mouthon Franck | 8 |
#2 | Charveriat Mathieu | 8 |
#3 | Jeanson Tiffany | 7 |
#4 | Franck Mouthon | 2 |
#5 | Tiffany Jeanson | 2 |
#6 | Mathieu Charveriat | 2 |
#7 | Droguerre Marine | 1 |
#8 | Duchene Adeline | 1 |
Publication | Filing date | Title |
---|---|---|
EP3593822A1 | Therapeutic and diagnostic applications of a new method of monitoring of neuroglial interaction memri) | |
KR20180035219A | Use of amitriptyline to block hemichannels in the brain and to enhance its in vivo efficacy |